SSA Listing 8.06: Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that can cause painful and debilitating symptoms. Living with HS, which is characterized by the development of extensive skin lesions in areas such as the axillae, inguinal areas, or perineum, can significantly impact an individual's quality of life. Recognizing the challenges faced by individuals with HS, the Social Security Administration (SSA) has specific criteria in place to evaluate disability claims related to this condition. In this blog post, we will explore how the SSA evaluates hidradenitis suppurativa for disability claims, focusing on the requirement of extensive and persistent skin lesions.
Understanding Hidradenitis Suppurativa:
Hidradenitis suppurativa is a chronic inflammatory skin disorder that affects areas rich in apocrine sweat glands, such as the axillae, groin, and perineum. It is characterized by the development of painful, deep-seated nodules, abscesses, and sinus tracts that can lead to scarring and recurrent infections. HS can cause significant pain, discomfort, and limitations in daily activities.
Evaluation Criteria:
The SSA evaluates disability claims related to hidradenitis suppurativa under Listing 8.06. To qualify for disability benefits, individuals must meet the following criteria:
Extensive Skin Lesions: The presence of extensive and persistent skin lesions involving both axillae, both inguinal areas, or the perineum is a key requirement. Extensive lesions refer to a significant and widespread involvement of these specific areas affected by HS. The severity and extent of the lesions are assessed based on medical evidence provided, such as detailed medical records, photographs, and reports from dermatologists or other healthcare professionals.
Persistence of Skin Lesions: The skin lesions must persist for at least three months despite continuing treatment as prescribed. This criterion recognizes the chronic nature of hidradenitis suppurativa and the challenges faced by individuals whose symptoms do not adequately respond to treatment.
Documenting Medical Evidence:
To support a disability claim for hidradenitis suppurativa, comprehensive and well-documented medical evidence is crucial. This includes detailed medical records, photographs of the skin lesions, biopsy reports, treatment plans, and reports from dermatologists or other specialists. The medical evidence should clearly demonstrate the extent and persistence of the skin lesions, the duration of their presence despite ongoing treatment, and the impact on the individual's daily functioning and ability to work.
Importance of Continuing Treatment:
While the persistence of skin lesions despite continuing treatment is a requirement for disability eligibility, it is essential for individuals with hidradenitis suppurativa to comply with prescribed treatments. The SSA expects individuals to actively engage in medical management to control and alleviate their symptoms. Evidence of consistent adherence to treatment plans can strengthen the disability claim and demonstrate the severity of the condition despite appropriate care.
Navigating the Disability Claims Process:
Navigating the disability claims process for hidradenitis suppurativa can be complex. Seeking assistance from healthcare providers experienced in working with disability claims or consulting with a disability attorney can provide valuable guidance and support throughout the application process. These professionals can help ensure that all necessary medical evidence is included, accurately reflecting the severity and impact of hidradenitis suppurativa on the individual's ability to work.
The SSA evaluates disability claims related to hidradenitis suppurativa based on specific criteria outlined in Listing 8.06. By meeting the requirements of extensive and persistent skin lesions involving specific areas for at least three months despite continuing treatment, individuals affected by hidradenitis suppurativa can pursue disability benefits. Gathering comprehensive medical evidence, including documentation of the extent and duration of skin lesions, is crucial in supporting the claim. By understanding the evaluation process and seeking appropriate guidance, individuals with hidradenitis suppurativa can navigate the disability claims process and access the support they need.